Latest Interest Rates News

Page 5 of 126
Diatreme Resources has set out a sizeable economic case for its Northern Silica Project, with a pre-tax NPV of $1.29 billion for the base case and $2.419 billion if production expands. The catch is more immediate: the company held $1.9 million in corporate cash at quarter-end, equivalent to about 2.4 quarters of funding at its reported spending rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Sheffield Resources says lenders to the Thunderbird mine have extended repayment deferrals and covenant waivers until 18 December 2026. A proposed standstill could push Kimberley Mineral Sands’ debt obligations out to June 2027, but the agreement remains unsigned.
Maxwell Dee
Maxwell Dee
30 Oct 2026
BCAL Diagnostics has completed clinical validation for BREASTESTplus 2 across all breast densities and is targeting a November launch, while expanding Avantect Multicancer access. The commercial push comes alongside $1.895 million in quarterly operating cash outflows, only $580,000 in cash at quarter end and a growing strategic stake in Genetic Signatures.
Ada Torres
Ada Torres
30 Oct 2026
Epsilon Healthcare delivered record September-quarter customer receipts of A$3.9 million, while nine-month revenue reached A$11.5 million. The growth story is strengthening, but cash fell to A$997,000 and quarterly operating cash flow remained negative.
Ada Torres
Ada Torres
30 Oct 2026
Zicom Group delivered a third consecutive profitable year, but revenue and shareholder earnings fell sharply after major gas-processing projects were completed. The ASX-listed industrial group has strengthened its balance sheet, though dividends remain deferred while it repays an $8.72 million shareholder loan.
Victor Sage
Victor Sage
30 Oct 2026
Cann Group’s September quarter delivered a sharp increase in revenue and exports as its Mildura GMP facility gained traction in Europe. But with just $49,000 in cash, $626,000 of undrawn debt capacity and an estimated 0.9 quarters of funding, the recovery still depends on collections and further financing.
Ada Torres
Ada Torres
30 Oct 2026
TZ Limited reduced net operating cash outflow to $275,000 in the September quarter, but ended with just $185,000 in cash against $5.055 million of drawn debt. The company says it has received funding proposals from more than one party, though no transaction has been completed.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Vintage Energy’s September quarter exposed a sharp liquidity squeeze, with unrestricted cash falling to $0.53 million and estimated funding covering just 0.7 quarters. The company is still advancing two gas wells and has accepted a new Queensland exploration tenement, but both initiatives depend on securing additional capital.
Victor Sage
Victor Sage
30 Oct 2026
Central Petroleum’s first new Palm Valley well is producing around 0.5 TJ/d, well below pre-completion expectations of 3-4 TJ/d, with water loading a possible cause. Cash fell to $14.9 million as drilling costs rose, leaving the company reliant on a planned clean-out and the next well, PV15, to restore momentum.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cassius Mining ended the September quarter with A$1.159 million in cash, equivalent to 0.35 quarters of funding at its reported current outgoings. The company is advancing environmental and social studies at its large Madagascar limestone project while awaiting a final Ghana arbitration award and seeking additional funding or a development partner.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Duxton Farms returned to positive operating cash flow in the September quarter, but its balance sheet remains stretched with a $13.98 million net overdraft and $103.25 million of drawn financing. A secured convertible note raise and a delayed asset sale are now central to the company’s funding position.
Ada Torres
Ada Torres
30 Oct 2026
Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive